Faran SABETI

Faran SABETI is an Associate Professor in Optometry and Vision Science at the University of Canberra. He holds adjunct positions as Associate Professor in Neuroscience at the Australian National University (since 2020) and is an active researcher in clinical vision science. His work focuses on objective perimetry, retinal function assessment, and translational rehabilitation strategies for vision disorders. SABETI leads and collaborates on projects addressing diabetic retinopathy, age-related macular degeneration, and mild traumatic brain injury-related vision deficits.

• Affiliations: University of Canberra (Optometry & Vision Science), Australian National University (Neuroscience)
• Educations:
  • PhD in Dichoptic Multifocal Pupillographic Perimetry (Australian National University, 2011)
  • Bachelor of Optometry (University of New South Wales, 2004)
  • Graduate Certificate in Ocular Therapeutics (University of New South Wales, 2011)
  • Fellow of Higher Education Academy (ANU, 2020)

Research Interests: His work spans objective perimetry techniques for early disease detection (glaucoma, diabetes-related retinopathy), retinal function biomarkers in AMD and diabetic maculopathy, and translational interventions like levodopa eye drops for vision restoration. He also investigates vision loss impact on quality-of-life domains like art appreciation and social interaction.

Key Projects (2023-2027):

• VA-RIS: Vision Assessment pathway in rehabilitation settings ($4M project)
• Stochastic resonance for visual aids in retinal disease ($3.5M)
• Enhancing dementia care in aged facilities through allied health integration ($6M)

Awards: 2020 Fellow of Higher Education Academy (ANU).

Grants & Collaborations: Active in interdisciplinary teams with clinicians, engineers, and neuroscientists. Leads studies on multifocal pupillography, diabetic eye disease biomarkers, and levodopa therapy safety.

Labs & Teams: Co-director of the Vision Science Research Group at UC, collaborating with institutions like UNSW, ANU, and industry partners in medical device development.